Active Pharmaceutical Ingredient (API) Market Size, Share & Industry Analysis, By Type (Generic API, and Branded API), By Synthesis (Biological API, and Synthetic API), and Regional Forecast, 2019-2026 (Includes COVID-19 Business Impact)

                                          
We have updated Active Pharmaceutical Ingredient (API) Market with respect to COVID-19 Business Impact.
Inquire before buying


This report focuses on the Active Pharmaceutical Ingredient (API) market and value at the global level, regional level, and company level. From a global perspective, this report represents the overall Active Pharmaceutical Ingredient (API) market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America.


Global Active Pharmaceutical Ingredient (API) Market: Segment Analysis


The research report includes specific segments by region (country), by Company, by Type, and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2019 to 2029. An in-depth analysis of the segments assists in identifying the different factors that will aid market growth.


Global Active Pharmaceutical Ingredient (API) Market: Regional Analysis


The research report includes a detailed study of regions of North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America. The report has been curated after observing and studying various factors that determine regional growth such as the economic, environmental, social, technological, and political status of the particular region. Researchers have studied the data of revenue, sales, and manufacturers of each mentioned region. This section analyses region-wise revenue and volume for the forecast period of 2019 to 2029.


Global Active Pharmaceutical Ingredient (API) Market: Competitive Landscape


This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2019 to 2029.
List of Companies Profiled

Strong Technical Capabilities have Propelled AbbVie, Teva, and Mylan at the Leading Position in the Market
The competitive landscape demonstrates a fragmented active pharmaceutical ingredient (API) market.  AbbVie Inc., Teva Pharmaceutical Industries Ltd., and Mylan N.V. are the top API companies with a diversified product portfolio, combined with the presence of state-of-the-art technology for the manufacturing of API. Core focus on API production by these companies, along with strategic partnerships with domestic players for securing raw materials, have been instrumental for the dominance of these companies in the API market.

Many contract manufacturing organizations are now solely focusing on developing biological APIs citing the lucrative opportunities in the API market. The market of active pharmaceutical ingredients (API) is further characterized by a large proportion of players in Asia Pacific focusing on developing generic APIs, while manufacturers in Europe and North America are moving towards biological API manufacturing. Other key players include Cipla Inc., Biocon, Amgen Inc., Dr. Reddys Laboratories Ltd, Sun Pharmaceutical Industries Ltd., and others.

LIST OF KEY COMPANIES PROFILED:

  
Teva Pharmaceutical Industries Ltd
  
AbbVie Inc.
  
Abbott
  
Aurobindo Pharma
  
Cipla Inc.
  
Dr. Reddys Laboratories Ltd
  
Sun Pharmaceutical Industries Ltd
  
Amgen Inc.
  
Biocon
  
Mylan N.V.
  
Others

KEY INDUSTRY DEVELOPMENTS:

February 2020 “   Sanofi plans to create a standalone company that would integrate with the companys six European API production sites engaged in the production and marketing to third parties of active pharmaceutical ingredients.

June 2016 -  AbbVie Inc., a U.S.-based company, expanded its small molecule active pharmaceutical ingredient manufacturing facility in Singapore to strengthen its oncology and women"s health pipeline.

 

REPORT COVERAGE

The active pharmaceutical ingredient (API) market report provides a detailed analysis of the market and focuses on key aspects such as leading companies, product types, and leading therapeutic applications of the different types of APIs. Besides this, the report offers insights into the active pharmaceutical ingredient (API) market trends and highlights key industry developments. In addition to the aforementioned factors, the report encompasses several factors that have contributed to the growth of the market over the recent years.

Report Scope & Segmentation

 Segmentation

By Type

  
Generic API
  
Branded API

By Synthesis

  
Biological API
  
Synthetic API

By Geography

  
North America (U.S. and Canada)
  
Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
  
Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia- Pacific)
  
Rest of the World